Doug Long, VP of industry relations for IMS Health, told attendees of the recent GPhA annual meeting that the generic industry is riding high.
Doug Long, VP of industry relations for IMS Health, told attendees of the recent GPhA annual meeting that the generic industry is riding high. "In 2001, generics represented 47% of prescriptions dispensed in the U.S.; today they represent 61% and it looks like it's going to go much higher in 2007." Long said that total Rx volume increased by 4.6% industrywide in 2006, while generic prescriptions increased by 13%, three times faster than the market. On a dollar basis, the total pharmaceutical market grew by 8.3%, while the generic business grew by 22.4%.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
How Mark Cuban Cost Plus Drug Company Is Approaching Drug Pricing Transparency
October 14th 2024Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.